Design, Synthesis and Cytotoxicity Evaluationof New 1,2-diaryl-4, 5, 6, 7-Tetrahydro-1H-benzo[<i>d</i>] Imidazolesas Tubulin Inhibitors

AuthorMarzieh Amirmostofianen
AuthorFarzad Kobarfarden
AuthorHamed Reihanfarden
AuthorVida Mashayekhien
AuthorAfshin Zarghien
Issued Date2015-01-31en
AbstractA new series of 1,2-diaryl-4,5,6,7-tetrahydro-1H-benzo[d]imidazoles, possessing trimethoxyphenyl pharmacophore, were synthesized to evaluate their biological activities as tubulin inhibitors. Cytotoxic activity of the synthesized compounds 7a-f was assessed against several human cancer cell lines, including MCF-7 (breast cancer cell), HEPG2 (liver hepatocellular cells), A549 (adenocarcinomic human alveolar basal epithelial cells), T47D (Human ductal breast epithelial tumor cell line) and fibroblast. According to our results, HEPG2 seems to be the most sensitive, while MCF7 was the most resistant cell line to the compounds. All the compounds expect 7b, possessed satisfactory activity against HEPG2 with mean IC50 values ranging from 15.60 to 43.81 µM.en
DOIhttps://doi.org/10.22037/ijpr.2015.1627en
Keyword4en
Keyword5en
Keyword6en
Keyword7-Tetrahydro-1H-benzo[d]imidazoleen
KeywordAntitubulinen
KeywordMolecular modelingen
KeywordCytotoxicityen
PublisherBrieflandsen
TitleDesign, Synthesis and Cytotoxicity Evaluationof New 1,2-diaryl-4, 5, 6, 7-Tetrahydro-1H-benzo[<i>d</i>] Imidazolesas Tubulin Inhibitorsen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-14-059.pdf
Size:
950.23 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF